Public disclosures
Page built 2026-09-29
Data as of 2026-09-29
Search

Bain Capital Life Sciences Inv: insider trades

Every open market trade Bain Capital Life Sciences Inv has filed with the SEC, when each filing appeared, and how the buys did against the S&P 500 once the filing was public.

Key Facts

  • Bain Capital Life Sciences Inv is listed as 10% Owner at HTFL, KLRA.
  • Between 2026-04-20 (20 April 2026) and 2026-04-30 (30 April 2026) Bain Capital Life Sciences Inv filed 1 open market buy worth $25M and 3 open market sales worth $59M.
  • Across 1 scored buy, Bain Capital Life Sciences Inv averaged -34.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.
  • Data as of 2026-09-29 (29 September 2026).
Open market buys 1 $25M
Open market sales 3 $59M
Avg vs S&P, 90d -34.7% 1 scored buys
Beat the S&P 0% 90 days after entry

Would copying Bain Capital Life Sciences Inv have paid?

prices as of 2026-09-28

The result. Across 1 scored buy, Bain Capital Life Sciences Inv averaged -34.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell.

Average return of Bain Capital Life Sciences Inv's open market buys against the S&P 500.
Days after entryScored buysAvg vs S&PBeat S&PEntry monthst statisticReading
30 days 1 -21.9% 0% 1 n/a too few trades to tell
90 days 1 -34.7% 0% 1 n/a too few trades to tell
180 days 0 n/a n/a n/a n/a too few trades to tell

A return curve needs at least 10 scored buys. Bain Capital Life Sciences Inv does not have enough yet.

Stocks traded

  1. HTFL3 trades, $59M
  2. KLRA1 trade, $25M

Every open market trade

as of 2026-09-29
4 trades.
Open market trades filed by Bain Capital Life Sciences Inv, newest first.
FiledStockTypeSharesPriceValue90 day vs S&P
30 Apr 2026 HTFL sell 254,110 $30.51 $7.8M n/a
30 Apr 2026 HTFL sell 797,133 $29.37 $23M n/a
30 Apr 2026 HTFL sell 948,757 $29.23 $28M n/a
20 Apr 2026 KLRA buy 1,562,500 $16.00 $25M -34.7%

Insider sales are shown but not scored, because they are often planned for tax or diversification reasons.

Frequently asked questions

What has Bain Capital Life Sciences Inv bought and sold?

Between 2026-04-20 (20 April 2026) and 2026-04-30 (30 April 2026) Bain Capital Life Sciences Inv filed 1 open market buy worth $25M and 3 open market sales worth $59M.

Did Bain Capital Life Sciences Inv's buys beat the market?

Across 1 scored buy, Bain Capital Life Sciences Inv averaged -34.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 0% of them ahead of the index. That result is too few trades to tell. Insider sales are not scored because they are often planned for tax or diversification reasons.

Sources: Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.